Protara Therapeutics, Inc. (TARA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 228.32M |
| Enterprise Value | 182.02M |
| P/E Ratio | -2.96 |
| PEG Ratio | -0.21 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.02 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.46 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.33 |
| Return On Equity | -0.39 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -362,000 |
| EBITDA | -57.08M |
| Net Income | -57.44M |
| Diluted EPS | -1.34 |
Balance Sheet
| Total Cash | 135.79M |
| Total Cash/Share | 3.17 |
| Total Debt | 3.06M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 15.69 |
| Book Value Per Share | 4.23 |
Price History
| 52-Week Change | 36.71 |
| 52-Week High | 7.82 |
| 52-Week Low | 2.97 |
| Moving Average 50 Days | 4.51 |
| Moving Average 200 Days | 5.33 |
Statistics
| Average Volume | 749,753 |
| Shares Outstanding | 38.59M |
| % Held by Institutions | 98.96 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | January 10, 2020 |
AD
